1. Home
  2. KRYS vs ESNT Comparison

KRYS vs ESNT Comparison

Compare KRYS & ESNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$283.19

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Logo Essent Group Ltd.

ESNT

Essent Group Ltd.

HOLD

Current Price

$61.00

Market Cap

5.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRYS
ESNT
Founded
2015
2008
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.9B
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
KRYS
ESNT
Price
$283.19
$61.00
Analyst Decision
Strong Buy
Buy
Analyst Count
10
7
Target Price
$244.20
$68.71
AVG Volume (30 Days)
308.4K
709.3K
Earning Date
02-18-2026
02-13-2026
Dividend Yield
N/A
2.03%
EPS Growth
275.72
N/A
EPS
6.66
6.87
Revenue
$373,164,000.00
$1,263,558,000.00
Revenue This Year
$36.14
$3.47
Revenue Next Year
$42.38
$1.01
P/E Ratio
$42.79
$8.87
Revenue Growth
54.51
2.04
52 Week Low
$122.80
$51.61
52 Week High
$295.98
$67.09

Technical Indicators

Market Signals
Indicator
KRYS
ESNT
Relative Strength Index (RSI) 72.25 39.04
Support Level $279.56 $58.61
Resistance Level $295.98 $62.57
Average True Range (ATR) 11.27 1.42
MACD 2.68 -0.62
Stochastic Oscillator 78.58 31.38

Price Performance

Historical Comparison
KRYS
ESNT

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About ESNT Essent Group Ltd.

Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products, title insurance, and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners.

Share on Social Networks: